%0 Generic
%A Pereyra-Rodriguez, Jose Juan
%A Poveda, José Luis
%A Rivero, Alvaro
%A Serra-Baldrich, Esther
%A Silvestre, Juan Francisco
%A Armario-Hita, José Carlos
%A Calleja, Miguel Angel
%A Carrascosa, Jose Manuel
%A Florez, Angeles
%A Herranz, Pedro
%A Comellas, Marta
%A Ortiz de Frutos, Francisco Javier
%T Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA)
%D 2024
%@ 0926-9959
%U https://hdl.handle.net/10668/28520
%X The increased understanding of atopic dermatitis (AD) pathophysiology has shed light on the underlying immunologic mechanisms and spurred the development of novel, more precisely targeted therapies. As new agents become available, assessing their added value is advisable. Yet the value of novel health interventions sometimes remains largely unmeasured and inadequately understood. Value assessment is challenging since it involves assessing the extent to which it meets current unmet needs. Therefore, it is necessary to establish the most relevant health outcomes from different stakeholders' perspectives.
%K Atopic dermatitis
%K Multi‑criteria decision analysis (MCDA)
%K Health-related quality of life (HRQoL)
%K Pruritus reduction
%K Disease activity control
%~